BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gauthiez E, Habfast-robertson I, Rüeger S, Kutalik Z, Aubert V, Berg T, Cerny A, Gorgievski M, George J, Heim MH, Malinverni R, Moradpour D, Müllhaupt B, Negro F, Semela D, Semmo N, Villard J, Bibert S, Bochud P; the Swiss Hepatitis C Cohort Study. A systematic review and meta-analysis of HCV clearance. Liver Int 2017;37:1431-45. [DOI: 10.1111/liv.13401] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 4.4] [Reference Citation Analysis]
Number Citing Articles
1 O'Brien TR, Yang HI, Groover S, Jeng WJ. Genetic Factors That Affect Spontaneous Clearance of Hepatitis C or B Virus, Response to Treatment, and Disease Progression. Gastroenterology 2019;156:400-17. [PMID: 30287169 DOI: 10.1053/j.gastro.2018.09.052] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 4.8] [Reference Citation Analysis]
2 Li Q, Liu S, Zhang S, Liu C, Sun M, Li C, Zhang X, Chen J, Yao Y, Shi L. Human leucocyte antigen but not KIR alleles and haplotypes associated with chronic HCV infection in a Chinese Han population. Int J Immunogenet 2019;46:263-73. [PMID: 30932338 DOI: 10.1111/iji.12425] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
3 Ghaderi-zefrehi H, Gholami-fesharaki M, Ghorbanzadeh A, Sadeghi F. Association of HLA Class II Alleles with Outcome of Hepatitis C Virus Infection: A Systematic Review and Meta-analysis. Hepat Mon 2021;21. [DOI: 10.5812/hepatmon.109493] [Reference Citation Analysis]
4 Pasternak AL, Ward KM, Luzum JA, Ellingrod VL, Hertz DL. Germline genetic variants with implications for disease risk and therapeutic outcomes. Physiol Genomics 2017;49:567-81. [PMID: 28887371 DOI: 10.1152/physiolgenomics.00035.2017] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
5 Chaisri S, Pabalan N, Tabunhan S, Tharabenjasin P, Sankuntaw N, Leelayuwat C. Effects of the killer immunoglobulin-like receptor (KIR) polymorphisms on HIV acquisition: A meta-analysis. PLoS One 2019;14:e0225151. [PMID: 31790432 DOI: 10.1371/journal.pone.0225151] [Reference Citation Analysis]
6 Bayraktar A, Akgül SU, Bakkaloğlu H, Temurhan S, Çınar ÇK, Çiftçi HŞ, Kaan Gök AF, Demir E, Oğuz FS, Türkmen A. Can Direct-Acting Antiviral Treatment Change the Immunologic Risk Profile in Patients Infected with Hepatitis C Virus Who Are on the Cadaveric Waiting List? Transplant Proc 2020;52:97-101. [PMID: 31901328 DOI: 10.1016/j.transproceed.2019.10.016] [Reference Citation Analysis]
7 Waldenström J, Kåberg M, Alanko Blomé M, Widell A, Björkman P, Nilsson S, Hammarberg A, Weiland O, Nyström K, Lagging M. Absence of interferon-λ 4 enhances spontaneous clearance of acute hepatitis C virus genotypes 1-3 infection. Scand J Gastroenterol 2021;56:855-61. [PMID: 34034600 DOI: 10.1080/00365521.2021.1925956] [Reference Citation Analysis]
8 Singh N, Ma M, Montano-Loza AJ, Bhanji RA. Learning from a rare phenomenon — spontaneous clearance of chronic hepatitis C virus post-liver transplant: A case report. World J Hepatol 2022; 14(2): 456-463 [DOI: 10.4254/wjh.v14.i2.456] [Reference Citation Analysis]
9 Huang MH, Li H, Xue R, Li J, Wang L, Cheng J, Wu Z, Li W, Chen J, Lv X, Li Q, Lan P, Zhao L, Yang Y, Peng Z, Jiang J. Up-regulation of glycolipid transfer protein by bicyclol causes spontaneous restriction of hepatitis C virus replication. Acta Pharm Sin B 2019;9:769-81. [PMID: 31384537 DOI: 10.1016/j.apsb.2019.01.013] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
10 Koncz B, Balogh GM, Papp BT, Asztalos L, Kemény L, Manczinger M. Self-mediated positive selection of T cells sets an obstacle to the recognition of nonself. Proc Natl Acad Sci U S A 2021;118:e2100542118. [PMID: 34507984 DOI: 10.1073/pnas.2100542118] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Zhang J, Chen N, Chen Z, Liu Y, Zheng K, Qiu Y, Zhang N, Zhu J, Yu H, He Q. Low Mannose Binding Lectin, but Not L-Ficolin, Is Associated With Spontaneous Clearance of Hepatitis C Virus After Infection. Front Immunol 2020;11:587669. [PMID: 33262767 DOI: 10.3389/fimmu.2020.587669] [Reference Citation Analysis]
12 Legrand N, David G, Rodallec A, Gaultier A, Salmon D, Cesbron A, Wittkop L, Raffi F, Gendzekhadze K, Retière C, Allavena C, Gagne K. Influence of HLA-C environment on the spontaneous clearance of hepatitis C in European HIV-HCV co-infected individuals. Clin Exp Immunol 2021;204:107-24. [PMID: 33314121 DOI: 10.1111/cei.13562] [Reference Citation Analysis]
13 Smith S, Honegger JR, Walker C. T-Cell Immunity against the Hepatitis C Virus: A Persistent Research Priority in an Era of Highly Effective Therapy. Cold Spring Harb Perspect Med 2021;11:a036954. [PMID: 32205413 DOI: 10.1101/cshperspect.a036954] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
14 Savoy SKA, Boudreau JE. The Evolutionary Arms Race between Virus and NK Cells: Diversity Enables Population-Level Virus Control. Viruses 2019;11:E959. [PMID: 31627371 DOI: 10.3390/v11100959] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
15 Cook L. Hepatitis C and the Impact of Host Genetics. J Mol Diagn 2017;19:805-8. [PMID: 28963021 DOI: 10.1016/j.jmoldx.2017.09.001] [Reference Citation Analysis]
16 Bhushan A, Chinnaswamy S. Identifying causal variants at the interferon lambda locus in case-control studies: Utilizing non-synonymous variant rs117648444 to probe the role of IFN-λ4. Gene 2018;664:168-80. [PMID: 29705128 DOI: 10.1016/j.gene.2018.04.076] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
17 Martinello M, Hajarizadeh B, Grebely J, Dore GJ, Matthews GV. Management of acute HCV infection in the era of direct-acting antiviral therapy. Nat Rev Gastroenterol Hepatol. 2018;15:412-424. [PMID: 29773899 DOI: 10.1038/s41575-018-0026-5] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 11.0] [Reference Citation Analysis]
18 Bavaro DF, Saracino A, Fiordelisi D, Bruno G, Ladisa N, Monno L, Angarano G. Influence of HLA-B18 on liver fibrosis progression in a cohort of HIV/HCV coinfected individuals. J Med Virol. 2019;91:751-757. [PMID: 30578670 DOI: 10.1002/jmv.25385] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
19 Frias M, Rivero-Juárez A, Rodriguez-Cano D, Camacho Á, López-López P, Risalde MÁ, Manzanares-Martín B, Brieva T, Machuca I, Rivero A. HLA-B, HLA-C and KIR improve the predictive value of IFNL3 for Hepatitis C spontaneous clearance. Sci Rep 2018;8:659. [PMID: 29330418 DOI: 10.1038/s41598-017-17531-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
20 Blunt MD, Khakoo SI. Activating killer cell immunoglobulin-like receptors: Detection, function and therapeutic use. Int J Immunogenet 2020;47:1-12. [PMID: 31755661 DOI: 10.1111/iji.12461] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
21 Huang P, Fan H, Tian T, Liao P, Li J, Yu R, Xia X, Feng Y, Wang J, Liu Y, Zhang Y, Yue M. The relationship between human leukocyte antigen-DP/DQ gene polymorphisms and the outcomes of HCV infection in a Chinese population. Virol J 2017;14:235. [PMID: 29212520 DOI: 10.1186/s12985-017-0901-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
22 Negro F. Natural History of Hepatic and Extrahepatic Hepatitis C Virus Diseases and Impact of Interferon-Free HCV Therapy. Cold Spring Harb Perspect Med 2020;10:a036921. [PMID: 31636094 DOI: 10.1101/cshperspect.a036921] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]